GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Institutional Ownership

Divi's Laboratories (NSE:DIVISLAB) Institutional Ownership : 23.38% (As of May. 26, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Divi's Laboratories's institutional ownership is 23.38%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Divi's Laboratories's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Divi's Laboratories's Float Percentage Of Total Shares Outstanding is 0.00%.


Divi's Laboratories Institutional Ownership Historical Data

The historical data trend for Divi's Laboratories's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Institutional Ownership Chart

Divi's Laboratories Historical Data

The historical data trend for Divi's Laboratories can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 24.00 23.79 24.61 24.54 24.61 24.56 24.39 24.51 23.99 23.38

Divi's Laboratories Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Divi's Laboratories (NSE:DIVISLAB) Business Description

Traded in Other Exchanges
Address
Divi Towers, 1-72/23(P)/DIVIS/303, Babukhan Lane, Cyber Hills, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Divi's Laboratories (NSE:DIVISLAB) Headlines

No Headlines